- In January 2024, GE Healthcare announced its agreement to acquire MIM Software, a prominent provider of medical imaging analysis and AI solutions. MIM Software specializes in key areas, including radiation oncology, molecular radiotherapy, diagnostic imaging, and urology across diverse healthcare environments. This acquisition will enhance GE Healthcare's capabilities in medical imaging and analytics, reinforcing its commitment to advancing patient care through innovative technologies
- In January 2024, Medtronic received U.S. FDA approval for its Percept RC Deep Stimulation System, featuring advanced BrainSense technology. This innovative system is designed to provide personalized treatment for patients with conditions such as Parkinson's disease and epilepsy. The approval underscores Medtronic's commitment to enhancing patient outcomes through cutting-edge neurostimulation solutions tailored to individual needs
- In April 2022, Boston Scientific Corporation obtained FDA 510(k) clearance for the EMBOLD Fibered Detachable Coil, designed to obstruct or diminish blood flow in the peripheral vasculature. This regulatory approval highlights the company's commitment to advancing medical technology in vascular treatments. The EMBOLD coil aims to enhance clinical outcomes by providing a reliable solution for managing blood flow-related conditions
- In June 2022, BD completed the acquisition of Parata Systems, a leading provider of pharmacy automation solutions. This strategic move enhances BD's portfolio by integrating Parata's innovative technologies, aimed at streamlining pharmacy operations. The acquisition is expected to bolster BD's commitment to improving medication management and patient safety through advanced automation solutions in the healthcare sector
- In April 2020, Scoutbee introduced a free tool designed to assist organizations in sourcing hospital supplies related to COVID-19. This initiative aimed to facilitate the procurement of essential medical equipment and supplies during the pandemic. By providing a streamlined search capability, Scoutbee contributed to addressing urgent healthcare needs and enhancing supply chain efficiency in the fight against COVID-19
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Diagnostic Supplies, Dialysis Consumables, Inhalation Products, Wound Care Consumables, Radiology Consumables, Infection Control Supplies, Infusion Products, Intubation and Ventilation Supplies, Personal Protection Equipment (PPE), Hypodermic Products, Sterilization Consumables, and Other Medical Supplies), Application (Urology, Wound Care, Radiology, Anaesthesia, Sterilization, Cardiology, Ophthalmology, and Other Applications), End User (Hospitals, Clinics/Physician Offices, Assisted Living Centres and Nursing Homes, Ambulatory Surgery Centres, and Other End Users) – Industry Trends and Forecast to 2031
.
The Global Medical Supplies Market size was valued at USD 159.99 USD Billion in 2023.
The Global Medical Supplies Market is projected to grow at a CAGR of 15.6% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
